Thyrotoxicosis and dyspnoea

Clin Endocrinol (Oxf). 1982 Jan;16(1):65-71. doi: 10.1111/j.1365-2265.1982.tb03148.x.

Abstract

Shortness of breath is a common symptom in thyrotoxicosis and it may have a number of causes. We have studied dyspnoea, skeletal muscle power and respiratory muscle power in eleven patients who had thyrotoxicosis with no evidence of heart failure. Four patients (36.4%) had a marked improvement with treatment in the maximal inspiratory pressure developed at the mouth. All four were breathless and had a proximal myopathy before treatment. This confirms the existence of a group of thyrotoxic patients with a reversible respiratory muscle myopathy which may explain the frequent finding of breathlessness on exertion in such patients.

MeSH terms

  • Adult
  • Aged
  • Carbimazole / therapeutic use
  • Dyspnea / etiology
  • Dyspnea / physiopathology*
  • Female
  • Humans
  • Hyperthyroidism / complications
  • Hyperthyroidism / drug therapy
  • Hyperthyroidism / physiopathology*
  • Male
  • Middle Aged
  • Muscles / physiopathology*
  • Respiratory Function Tests
  • Thyroid Function Tests

Substances

  • Carbimazole